View Enlarged Image One catalyst that could push the stock higher is positive phase-three study results for sarilumab, a human antibody to treat rheumatoid arthritis. Regeneron is developing the treatment with partner …
Investor's Business Daily · 11/13/2015
The stock soared another 75% Friday ... company's history came from funding for research and development and licensing fees from drug giants Sanofi (SNY)and Novartis (NVS). KaloBios had previously tried to develop …
CNN Money · ByPaul R. La · 11/21/2015
I've seen a lot of players up close. He has Rajon Rondo talent. He can get a lot better offensively, which is crazy to say," said Jimmy Engles, according to Dunn had a ridiculous game on Monday against NJIT as …
HNGN · 1 day ago
NBA Draft
We think ENDP, SNY’s Merial / EU generics business ... That’s a no brainer given how far the stock climbed (at one point passing the $200 mark) after Mylan made its initial offer in early April. And having rejected all of Mylan’s offers as ...
Barron's · ByJohanna Bennett · 11/13/2015
Mylan Win
ALSO READ: 10 Stocks to Own for the Next Decade AT&amp ... 10 Brands That Will Disappear in 2016 Sanofi (NYSE: SNY) was the same position at 3.905 million shares. Suncor Energy Inc. (NYSE: SU) appears to be a LARGER STAKE of 30 million …
Market Watch · 11/16/2015
Berkshire Hathaway
Sanofi SA (NYSE:SNY) was downgraded by stock analysts at Sanford C. Bernstein from an “outperform” rating to a “market perform” rating in a research note issued on Monday, The Fly reports. They currently … · 11/12/2015
Sanofi SA
Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >> SANOFI (SNY): Free Stock Analysis Report Zacks Investment Research Personal Investing Ideas & Strategies Finance Trading Sanofi
Yahoo Finance · 10/29/2014
Sanofi is listed in Paris (EURONEXT: SAN: and in New York (NYSE: SNY: About Regeneron Pharmaceuticals, Inc.
4 Traders · 11/24/2015
Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). About Regeneron Pharmaceuticals, Inc. Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents …
Stock World · 11/24/2015
Regeneron Announce
KaloBios shares, already in penny stock territory, were down 55% in premarket trading ... which raised $90 million in its IPO and once struck a $290 million collaboration deal with Sanofi ($SNY). The pharma giant was lured in by the prospects of a cystic ...
Fierce Biotech · ByJohn Carroll · 11/16/2015